Teresa Shaffer
Adult Health · Boardman, OHNPI 1770092900
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $66,579 of the $101,508 with a category attached, or 65.6%. Johnson & Johnson accounts for 93.2% of it on its own, with 26 other manufacturers making up the rest. Among adult health clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 460 payments — averaging $220.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$95K
- AbbVie$2K
- Sanofi$701
- E.r. Squibb & Sons, L.L.C.$689
- Janssen Scientific Affairs, LLC$565
- Dermavant Sciences, Inc.$371
- plus $3K from 21 others
What the payments were for
- Consulting fees$1,6002%
- Speaking & faculty fees$66,57966%
- Travel & lodging$21,63121%
- Food & beverage$11,14511%
- Education$5531%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 199 | $94,645 |
| AbbVie(2 entities) | 84 | $1,846 |
| Sanofi | 25 | $701 |
| E.r. Squibb & Sons, L.L.C. | 28 | $689 |
| Janssen Scientific Affairs, LLC | 10 | $565 |
| Dermavant Sciences, Inc. | 18 | $371 |
| Revance Therapeutics, Inc. | 6 | $290 |
| Incyte Corporation | 8 | $271 |
| Novartis | 13 | $263 |
| UCB, Inc. | 11 | $249 |
| Regeneron Healthcare Solutions, Inc. | 9 | $245 |
| Galderma Laboratories, L.p. | 8 | $197 |
| Sun Pharmaceutical Industries Inc. | 7 | $165 |
| Merz North America, Inc. | 2 | $164 |
| Lilly USA, LLC | 4 | $157 |
| LEO Pharma Inc. | 5 | $138 |
| Journey Medical Corporation | 1 | $97 |
| Amgen | 5 | $95 |
| Pfizer | 5 | $77 |
| Boehringer Ingelheim | 3 | $73 |
| Sanofi-aventis U.S. LLC | 1 | $70 |
| Organon | 3 | $54 |
| Organogenesis Inc. | 1 | $31 |
| Kyowa Kirin, Inc. | 1 | $17 |
| Verrica Pharmaceuticals Inc. | 1 | $16 |
| Strata Skin Sciences, Inc. | 1 | $14 |
| Mayne Pharma Commercial LLC | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$101,508 in reported general payments places this provider in the 95th percentile of 1,184 adult health providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 11 | $42,049 |
| Clobetasol Propionate | 119 | $4,223 |
| Ketoconazole | 127 | $2,033 |
| Triamcinolone Acetonide | 130 | $1,288 |
| Metronidazole | 25 | $1,079 |
| Fluocinonide | 14 | $958 |
| Desonide | 24 | $926 |
| Doxycycline Hyclate | 49 | $574 |
| Clindamycin Phosphate | 11 | $402 |
| Imiquimod | 15 | $390 |
| Mometasone Furoate | 19 | $377 |
| ValacyclovirValacyclovir Hcl | 14 | $320 |
| Minocycline Hcl | 23 | $219 |
| Mupirocin | 25 | $153 |
Paid to pharmacies, not to this prescriber.
Other adult health in Boardman
- Emily DuezBoardman$8K
- Bonnie MohlerCanton$338K
- Andrew GuinigundoCincinnati$215K
- Gabriella McCartyWestlake$177K
- Karen SteffeyLyndhurst$145K
- Marie ChambersCenterville$134K
- Susan FlickCleveland$131K
- Jesse McClainYoungstown$79K
- Lucretia LongColumbus$76K
- Marybeth RivardColumbus$41K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.